Rockville, Md. – A new study for the Centers for Disease Control and Prevention confirms what health experts have long argued: mask use, vaccinations, and boosters reduce the risk of COVID-19 reinfection.
The study, which Abt Global co-authored, looked at previously infected essential and frontline workers who have participated in studies of SARS-CoV-2 since July 2020. Beyond the benefits of frequent mask use and vaccination, the study found that those with a third dose of mRNA vaccine had the lowest risk of reinfection with Omicron. The Omicron variant had a greater potential for reinfection than previous variants. Two or three doses of an mRNA vaccine reduced the risk of reinfection by more than 50%.
The biggest risk factors for reinfection included infrequent mask use and a first infection more than a year earlier. Demographically, the non-Hispanic Black population was most at risk. “As ever greater numbers of the population have been infected, understanding the risk factors for reinfection has become much more critical,” says Brian Sokol, vice president, Digital Delivery.
The study adds that “Protecting workers from SARS-CoV-2 reinfection requires a multipronged public health approach including up-to-date vaccination, mask use as recommended, and reduction in underlying health disparities.”
The results came from data gathered from 4,707 frontline workers in eight locations enrolled in two studies: the Arizona Healthcare, Emergency Response, and Other Essential workers Study and the Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel study. Participants self-collected weekly nasal specimens regardless of symptoms and when they felt the onset of COVID-19–like illness symptoms.
You can find the article here: https://wwwnc.cdc.gov/eid/article/29/3/22-1314_article
About Abt Global
Abt Global is a global consulting and research firm that combines data and bold thinking to improve the quality of people's lives. We partner with clients and communities to advance equity and innovation—from creating scalable digital solutions and combatting infectious disease, to mitigating climate change and evaluating programs for measurable social impact. https://www.abtglobal.com
Contact:
Stan Crock
stan_crock@abtassoc.com
(301) 347-5402
Read Our Latest News
Abt to Evaluate Sickle Cell Disease Treatment; Improve Quality in Nursing Homes, Post-Acute Care Settings
Abt Global is helping CMS determine whether a new program increases access to cell and gene therapy treatment while reducing healthcare costs.
Abt to Manage Australia’s Main Development Program for Fiji
The Australian Government recently awarded Abt Global a contract to manage a $90 million umbrella program covering half of Australia’s development assistance to Fiji.
Abt Leads Decision Support for FCDO Land Governance Programme
Abt Global Britain has been appointed to lead the Decision Support Unit of the Land Facility, funded by the UK’s Foreign and Commonwealth Development Office.
Public Warning: Recruitment Phishing Scam Impersonating Abt Global
Abt Global has become aware of a phishing scheme targeting individuals with fraudulent interview requests and job offers. Abt’s secure IT systems and private applicant information have not been compromised; scammers are impersonating Abt employees, using the company name and branding to mislead and engage potential job seekers in fake recruitment processes. Scammers might reference real job openings or describe fake opportunities that generally match individuals’ professional backgrounds, with the goal of establishing communication and eventually obtaining private financial information to defraud people. The Federal Bureau of Investigation and Federal Trade Commission warn that employment scams such as this are a growing cyber threat. Abt urges anyone who is contacted about employment opportunities to exercise caution and know that: All communication from Abt Global will be from an Abt employee using the @abtglobal.com email domain (e.g., recruiting@abtglobal.com). We do not use third-party recruiters. Abt Global recruiters will only schedule interviews for candidates who have applied for a position through our secure portal. You may view your application status through the applicant portal on Abt Global Careers. No corporate or IT systems at Abt are affected by this scam. The scammers are using Abt’s logo and employee names to impersonate the company. You can directly contact us at recruiting@abtglobal.com with any questions or concerns. Abt is committed to ensuring the safety and security of our community. We caution individuals to be vigilant in protecting personal data and vetting communication with new contacts from any company. Do not respond or provide any personal information if contacted by someone claiming to represent a company to which you did not submit a job application or profile. This scam can be perpetrated against any business and individuals who recognize and trust its name. For information on Abt recruitment practices and policies, please visit our careers page or email recruiting@abtglobal.com. To report a scam, visit: https://reportfraud.ftc.gov/.